Bioscience Animal Health PCL
Bioscience Animal Health Public Company Limited manufactures and distributes pharmaceutical supplies, devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. The compa… Read more
Market Cap & Net Worth: Bioscience Animal Health PCL (BIS)
Bioscience Animal Health PCL (BK:BIS) has a market capitalization of $18.47 Million (฿640.56 Million) as of March 18, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #31403 globally and #676 in its home market, demonstrating a 3.03% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioscience Animal Health PCL's stock price ฿2.04 by its total outstanding shares 314000000 (314.00 Million).
Bioscience Animal Health PCL Market Cap History: 2022 to 2026
Bioscience Animal Health PCL's market capitalization history from 2022 to 2026. Data shows change from $68.20 Million to $18.47 Million (-30.59% CAGR).
Bioscience Animal Health PCL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioscience Animal Health PCL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Bioscience Animal Health PCL's market cap is 0.01 times its annual revenue
0.14x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.41x
Bioscience Animal Health PCL's market cap is 0.41 times its annual earnings
5.50x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $68.20 Million | $2.19 Billion | $55.91 Million | 0.03x | 1.22x |
| 2023 | $42.78 Million | $2.41 Billion | $50.70 Million | 0.02x | 0.84x |
| 2024 | $26.62 Million | $2.32 Billion | $65.04 Million | 0.01x | 0.41x |
Competitor Companies of BIS by Market Capitalization
Companies near Bioscience Animal Health PCL in the global market cap rankings as of March 18, 2026.
Key companies related to Bioscience Animal Health PCL by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Bioscience Animal Health PCL Historical Marketcap From 2022 to 2026
Between 2022 and today, Bioscience Animal Health PCL's market cap moved from $68.20 Million to $ 18.47 Million, with a yearly change of -30.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿18.47 Million | +4.08% |
| 2025 | ฿17.75 Million | -33.33% |
| 2024 | ฿26.62 Million | -37.77% |
| 2023 | ฿42.78 Million | -37.26% |
| 2022 | ฿68.20 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bioscience Animal Health PCL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.47 Million USD |
| MoneyControl | $18.47 Million USD |
| MarketWatch | $18.47 Million USD |
| marketcap.company | $18.47 Million USD |
| Reuters | $18.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.